These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 32854147)
1. Can a gluten-free diet be partly protective for COVID-19 infection? Haupt-Jorgensen M; Buschard K APMIS; 2020 Oct; 128(10):558-559. PubMed ID: 32854147 [No Abstract] [Full Text] [Related]
2. Facing the COVID-19 outbreak: What should we know and what could we do? Yang Y; Shang W; Rao X J Med Virol; 2020 Jun; 92(6):536-537. PubMed ID: 32091134 [No Abstract] [Full Text] [Related]
3. SARS-CoV-2 immunogenicity at the crossroads. Karamloo F; König R Allergy; 2020 Jul; 75(7):1822-1824. PubMed ID: 32401346 [No Abstract] [Full Text] [Related]
4. Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19. Fu J; Zhou B; Zhang L; Balaji KS; Wei C; Liu X; Chen H; Peng J; Fu J Mol Biol Rep; 2020 Jun; 47(6):4383-4392. PubMed ID: 32410141 [TBL] [Abstract][Full Text] [Related]
5. Scientific research progress of COVID-19/SARS-CoV-2 in the first five months. Li H; Liu Z; Ge J J Cell Mol Med; 2020 Jun; 24(12):6558-6570. PubMed ID: 32320516 [TBL] [Abstract][Full Text] [Related]
6. Sodium status and kidney involvement during COVID-19 infection. Post A; Dullaart RPF; Bakker SJL Virus Res; 2020 Sep; 286():198034. PubMed ID: 32445872 [TBL] [Abstract][Full Text] [Related]
7. Testing of natural products in clinical trials targeting the SARS-CoV-2 (Covid-19) viral spike protein-angiotensin converting enzyme-2 (ACE2) interaction. Williamson G; Kerimi A Biochem Pharmacol; 2020 Aug; 178():114123. PubMed ID: 32593613 [TBL] [Abstract][Full Text] [Related]
8. Use of inhaled corticosteroids in asthma and coronavirus disease 2019: Keep calm and carry on. Lipworth B; Chan R; Kuo CR Ann Allergy Asthma Immunol; 2020 Nov; 125(5):503-504. PubMed ID: 32585180 [No Abstract] [Full Text] [Related]
9. mRNA Vaccines: Possible Tools to Combat SARS-CoV-2. Yi C; Yi Y; Li J Virol Sin; 2020 Jun; 35(3):259-262. PubMed ID: 32524253 [No Abstract] [Full Text] [Related]
10. The pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses. Feliciello I; Procino A Hum Vaccin Immunother; 2020 Oct; 16(10):2373. PubMed ID: 32401611 [TBL] [Abstract][Full Text] [Related]
11. How does SARS-CoV-2 cause COVID-19? Matheson NJ; Lehner PJ Science; 2020 Jul; 369(6503):510-511. PubMed ID: 32732413 [No Abstract] [Full Text] [Related]
15. Prevention of Severe Coronavirus Disease 2019 Outcomes by Reducing Low-Grade Inflammation in High-Risk Categories. Ciornei RT Front Immunol; 2020; 11():1762. PubMed ID: 32760408 [No Abstract] [Full Text] [Related]
16. COVID-19 and relative angiotensin-converting enzyme 2 deficiency: role in disease severity and therapeutic response. Ryan PM; Caplice N Open Heart; 2020 Jun; 7(1):. PubMed ID: 32532804 [No Abstract] [Full Text] [Related]
17. COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles' heel conserved region to minimize probability of escape mutations and drug resistance. Robson B Comput Biol Med; 2020 Jun; 121():103749. PubMed ID: 32568687 [TBL] [Abstract][Full Text] [Related]
18. Novel coronavirus SARS-CoV-2 (Covid-19) dynamics inside the human body. Saha A; Saha B Rev Med Virol; 2020 Sep; 30(5):e2140. PubMed ID: 32686248 [TBL] [Abstract][Full Text] [Related]